More articles from IMMUNOTHERAPY AND VACCINES

You have accessRestricted access
Improved Durability to SARS-CoV-2 Vaccine Immunity following Coimmunization with Molecular Adjuvant Adenosine Deaminase-1
Gina M. Cusimano, Ebony N. Gary, Matthew R. Bell, Bryce M. Warner, Jennifer Connors, Nicholas J. Tursi, Ali R. Ali, Shiyu Zhang, Gabriela Canziani, Bhavani Taramangalam, Emma A. Gordon, Irwin M. Chaiken, Sarah K. Wootton, Trevor Smith, Stephanie Ramos, Darwyn Kobasa, David B. Weiner, Michele A. Kutzler and Elias K. Haddad

J Immunol 209 (1) 118-127; July 1, 2022, doi: https://doi.org/10.4049/jimmunol.2200056
Open Access
Viral Delivery of IL-7 Is a Potent Immunotherapy Stimulating Innate and Adaptive Immunity and Confers Survival in Sepsis Models
Karine Lélu, Clarisse Dubois, Alexei Evlachev, Morgane Crausaz, Marie Baldazza, Nadine Kehrer, Renée Brandely, Yasmin Schlesinger, Nathalie Silvestre, Jean-Baptiste Marchand, Bérangère Bastien, Stéphane Leung-Theung-Long, Jacqueline Unsinger, Perrine Martin and Geneviève Inchauspé

J Immunol 209 (1) 99-117; July 1, 2022, doi: https://doi.org/10.4049/jimmunol.2101145
You have accessRestricted access
SM03, an Anti-CD22 Antibody, Converts Cis-to-Trans Ligand Binding of CD22 against α2,6-Linked Sialic Acid Glycans and Immunomodulates Systemic Autoimmune Diseases
Kin L. Wong, Zhengdong Li, Felix Ma, Dong Wang, Nan Song, Chi H. Chong, Ka K. Luk and Shui O. Leung

J Immunol 208 (12) 2726-2737; June 15, 2022, doi: https://doi.org/10.4049/jimmunol.2100820
You have accessRestricted access
IL-10 Receptor Blockade Delivered Simultaneously with Bacillus Calmette–Guérin Vaccination Sustains Long-Term Protection against Mycobacterium tuberculosis Infection in Mice
Varun Dwivedi, Shalini Gautam, Colwyn A. Headley, Tucker Piergallini, Jordi B. Torrelles and Joanne Turner

J Immunol 208 (6) 1406-1416; March 15, 2022, doi: https://doi.org/10.4049/jimmunol.2100900
You have accessRestricted access
Development of a Nanoparticle Multiepitope DNA Vaccine against Virulent Infectious Bronchitis Virus Challenge
Yifeng Qin, Qingyuan Teng, Delan Feng, Yu Pei, Ye Zhao and Guozhong Zhang

J Immunol 208 (6) 1396-1405; March 15, 2022, doi: https://doi.org/10.4049/jimmunol.2100909
Open Access
Boosting of the SARS-CoV-2–Specific Immune Response after Vaccination with Single-Dose Sputnik Light Vaccine
Alexey A. Komissarov, Inna V. Dolzhikova, Grigory A. Efimov, Denis Y. Logunov, Olga Mityaeva, Ivan A. Molodtsov, Nelli B. Naigovzina, Iuliia O. Peshkova, Dmitry V. Shcheblyakov, Pavel Volchkov, Alexander L. Gintsburg and Elena Vasilieva

J Immunol 208 (5) 1139-1145; March 1, 2022, doi: https://doi.org/10.4049/jimmunol.2101052
Open Access
Microfluidic Squeezing Enables MHC Class I Antigen Presentation by Diverse Immune Cells to Elicit CD8⁺ T Cell Responses with Antitumor Activity
Matthew G. Booty, Kelan A. Hlavaty, Adam Stockmann, Emrah Ilker Ozay, Carolyne Smith, Lina Tian, Edylle How, Disha Subramanya, Anita Venkitaraman, Christian Yee, Olivia Pryor, Kelly Volk, Katarina Blagovic, Ildefonso Vicente-Suarez, Defne Yarar, Melissa Myint, Amy Merino, Jonathan Chow, Tarek Abdeljawad, Harry An, Sophia Liu, Shirley Mao, Megan Heimann, LeeAnn Talarico, Miye K. Jacques, Eritza Chong, Lucas Pomerance, John T. Gonzalez, Ulrich H. von Andrian, Klavs F. Jensen, Robert Langer, Hendrik Knoetgen, Christine Trumpfheller, Pablo Umaña, Howard Bernstein, Armon Sharei and Scott M. Loughhead

J Immunol 208 (4) 929-940; February 15, 2022, doi: https://doi.org/10.4049/jimmunol.2100656
Open Access
Mucosal Vaccination with Cyclic Dinucleotide Adjuvants Induces Effective T Cell Homing and IL-17–Dependent Protection against Mycobacterium tuberculosis Infection
Robyn M. Jong, Erik Van Dis, Samuel B. Berry, Xammy Nguyenla, Alexander Baltodano, Gabrielle Pastenkos, Chenling Xu, Douglas Fox, Nir Yosef, Sarah M. McWhirter and Sarah A. Stanley

J Immunol 208 (2) 407-419; January 15, 2022, doi: https://doi.org/10.4049/jimmunol.2100029
Open Access
Combination Immune Checkpoint Blockade Enhances IL-2 and CD107a Production from HIV-Specific T Cells Ex Vivo in People Living with HIV on Antiretroviral Therapy
Chris Y. Chiu, Judy J. Chang, Ashanti I. Dantanarayana, Ajantha Solomon, Vanessa A. Evans, Rachel Pascoe, Céline Gubser, Lydie Trautman, Rémi Fromentin, Nicolas Chomont, James H. McMahon, Paul U. Cameron, Thomas A. Rasmussen and Sharon R. Lewin

J Immunol 208 (1) 54-62; January 1, 2022, doi: https://doi.org/10.4049/jimmunol.2100367
You have accessRestricted access
Selective Inhibition of the Interaction between SARS-CoV-2 Spike S1 and ACE2 by SPIDAR Peptide Induces Anti-Inflammatory Therapeutic Responses
Ramesh K. Paidi, Malabendu Jana, Rama K. Mishra, Debashis Dutta and Kalipada Pahan

J Immunol 207 (10) 2521-2533; November 15, 2021, doi: https://doi.org/10.4049/jimmunol.2100144

Main menu

User menu

Search

More articles from IMMUNOTHERAPY AND VACCINES

Pages

Navigate

For Authors

General Information

Journal Services